Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.58 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.58 |
| ▸ | BAX | Q07812 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.54 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29458645 | 1.00 | LTA4H (0.58) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL5027612 | 1.00 | LTA4H (0.58) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL13899983 | 0.98 | MEN1 (0.58) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL37670120 | 0.95 | LTA4H (0.67) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL70648 | 0.95 | LTA4H (0.67) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL9385056 | 0.95 | LTA4H (0.67) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL28419866 | 0.95 | LTA4H (0.67) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL813557 | 0.95 | CYP3A4 (0.58) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL30358272 | 0.95 | CYP3A4 (0.58) | LTA4HNR1H2BAXMEN1KMT2A | |
| SCHEMBL8069693 | 0.93 | CYP3A4 (0.54) | LTA4HNR1H2BAXMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240052103-A1 | POLYMER AND TRIAZINE COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-02-15 | — | — | US | disclosed |
| EP-0863926-B1 | A PROCESS FOR THE PRODUCTION OF CYANATE ESTER RESINS HAVING UNIQUE COMPOSITION | ALLIED SIGNAL INC (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0863926-A1 | A PROCESS FOR THE PRODUCTION OF CYANATE ESTER RESINS HAVING UNIQUE COMPOSITION | AlliedSignal Incorporated (US) | 1998-09-16 | — | — | EP | disclosed |
| US-5756592-A | FROM PHENOLIC RESINS | ALLIEDSIGNAL, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1997019970-A1 | A PROCESS FOR THE PRODUCTION OF CYANATE ESTER RESINS HAVING UNIQUE COMPOSITION | ALLIEDSIGNAL INC. (US) | 1997-06-05 | — | — | WO | disclosed |
| US-5157105-A | Heat curable; thermosetting resins with improved toughness | SHELL OIL COMPANY (US) | 1992-10-20 | — | — | US | disclosed |
| EP-0411707-A1 | Preparation of cyanate esters | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-02-06 | — | — | EP | disclosed |
| US-4981994-A | Preparation of cyanate esters | SHELL OIL COMPANY (US) | 1991-01-01 | — | — | US | disclosed |
| US-4094861-A | Process for the production of non-inflammable polytriazines | BAYER AKTIENGESELLSCHAFT (DT) | 1978-06-13 | — | — | US | disclosed |
| US-4049630-A | Process for preparation of s-triazine prepolymers | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-20 | — | — | US | disclosed |
| US-4046796-A | Process for the production of polyfunctional cyanic acid esters | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-06 | — | — | US | disclosed |
| US-4028393-A | Process for the production of polyfunctional cyanic acid esters | BAYER AKTIENGESELLSCHAFT (DT) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240052103-A1 | POLYMER AND TRIAZINE COMPOUND | TERT, TERB1, MCM5 | LTA4H 1396/4885NR1H2 1712/4885BAX 2299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.